ReviewACS pharmacology & translational science2025
Opiophobia: Misinformation, Misconceptions, Misrepresentations, Perspectives, and Consequences.
Review in ACS pharmacology & translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A continuing narrative regarding the opioid epidemic is that even short-term (7 days or less) use of opioids under medical supervision to treat acute pain will often lead to opioid use disorder (OUD) and/or addiction. It is also believed by some that the best way to address this perceived problem is to avoid using opioids altogether or to severely limit the use of prescription opioids, especially after surgery. It is further believed by some that severely limiting the number of prescriptions will greatly reduce the number of deaths due to opioid overdoses occurring as a consequence of the opioid epidemic. There is, however, substantial evidence that this is not the case. This review/commentary explores this evidence in the context of organizations, researchers, and clinicians that strive to further drastically decrease or eliminate the use of prescription opioids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.